HIV-1 infection remains a significant global health challenge, primarily due to its ability to establish a latent reservoir within the host's immune cells, particularly CD4 + T cells. This ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more vulnerable to diseases and infections. Once inside human cells ...

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

HIV gradually weakens the body’s immune system by infecting and destroying white blood cells called T-cells ... have died globally because of HIV infection to date. This includes 770,000 ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed ... according to the firm. T cells, a type of white blood cells, attack and kill infected cells. Immuno Cure said it plans ...

Since those fateful days, almost 90 million people around the world have been infected with HIV, and more than 40 million ...

People whose CD4 T-cell count remains below 200 or even 350 are more prone to AIDS-related events and non-AIDS infections.

Importantly, the interaction between CXCR4 and its ligand SDF-1 is involved in various disease conditions, such as cancer cell metastasis ... diseases as well as HIV infection.